Literature DB >> 20554281

Occult impaired glucose regulation in patients with atherosclerosis is associated to the number of affected vascular districts and inflammation.

Stefano Rizza1, Marina Cardellini, Eugenio Martelli, Ottavia Porzio, Chiara Pecchioli, Antonio Nicolucci, Nikolaus Marx, Davide Lauro, Arnaldo Ippoliti, Franco Romeo, Renato Lauro, Massimo Federici.   

Abstract

OBJECTIVE: The role of inflammatory adipokines has clear mechanistic effects in the promotion of both DM2 and cardiovascular diseases (CVDs), but it is unknown to what extent atherosclerosis-related inflammation might promote defects of glucose metabolism. The purpose of this study was to test the hypothesis that in subjects with atherosclerotic vascular disease and no previous medical record of type 2 diabetes mellitus (DM2), the diagnosis of occult impaired glucose regulation (IGR) is related to the severity of atherosclerosis, measured as the single or combined presence of an history of coronary artery disease (CAD), carotid atherosclerosis (Car-ATS) and peripheral artery disease (PAD).
METHODS: In a population of 551 subjects (440 men and 111 women) with a previous history of atherosclerosis, we investigated the presence of IGR (including both impaired glucose tolerance and DM2). To test the correlation between conventional and non-conventional risk factors for cardiovascular disease and diabetes we used logistic and regression analysis models.
RESULTS: IGR was more prevalent in patients with a documented vascular disease in two or three vessel districts compared with patients with only one symptomatic district (p=0.016). Among classic risk factors we found that waist circumference was correlated neither to IGR nor to symptomatic vascular disease extension. By contrast, adiponectin level was independently associated to vascular and glucose regulation status (p=0.012 and p<0.001, respectively).
CONCLUSION: In subjects affected by atherosclerotic vascular diseases, the presence of impaired glucose regulation is associated to the number of vascular districts affected and to a reduced adiponectin level. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554281     DOI: 10.1016/j.atherosclerosis.2010.05.017

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

Review 1.  Kidney aging--inevitable or preventable?

Authors:  Devasmita Choudhury; Moshe Levi
Journal:  Nat Rev Nephrol       Date:  2011-08-09       Impact factor: 28.314

2.  Inclusion of plasma lipid species improves classification of individuals at risk of type 2 diabetes.

Authors:  Gerard Wong; Christopher K Barlow; Jacquelyn M Weir; Jeremy B M Jowett; Dianna J Magliano; Paul Zimmet; Jonathan Shaw; Peter J Meikle
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

3.  The relationship between glycated hemoglobin and complexity of coronary artery lesions among older patients with diabetes mellitus.

Authors:  Jinling Ma; Xiujie Wang; Yutang Wang; Yuexiang Zhao; Meng Gao; Xiaoqian Li
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

4.  Quality-of-Life Determinants in People with Diabetes Mellitus in Europe.

Authors:  Álvaro Fuentes-Merlos; Domingo Orozco-Beltrán; Jose A Quesada Rico; Raul Reina
Journal:  Int J Environ Res Public Health       Date:  2021-06-28       Impact factor: 3.390

5.  Metabolic Syndrome in an Aging Society - Role of Oxidant-Antioxidant Imbalance and Inflammation Markers in Disentangling Atherosclerosis.

Authors:  Sylwia Dziegielewska-Gesiak
Journal:  Clin Interv Aging       Date:  2021-06-09       Impact factor: 4.458

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.